同步辐射微束放疗与均匀放疗诱导脑肿瘤血管通透性变化的比较
研究比较同步辐射微束放疗(MRT)与均匀宽束放疗(BB)对F98胶质瘤大鼠血脑屏障通透性的影响。MRT不改变正常脑组织血管通透性,但诱导肿瘤血管通透性增加更显著、更早且更持久,尤其在高增殖肿瘤区域;BB仅在T7增强血管通透性。
要点
- MRT不改变正常脑组织血管通透性
- MRT诱导肿瘤血管通透性增加早于BB且更持久
- MRT对高氧合、高增殖肿瘤区域更有效
核心结论
- MRT诱导的肿瘤血管通透性增加显著大于BB,且更早、更持久,尤其在高度增殖肿瘤区域
- MRT靶向所有按生理特征区分的肿瘤区域,包括均匀照射未损伤的区域
研究设计与样本
- 雄性F98胶质瘤大鼠随机分为3组:未治疗组、MRT组(峰剂量241 Gy,谷剂量10.5 Gy)、BB组(剂量等效于MRT谷剂量)
- 两组均采用2个正交阵列交叉照射肿瘤区域
- 治疗前1天及治疗后1、2、7、14天通过磁共振成像监测血管通透性
主要发现
- MRT不改变正常脑组织血管通透性
- MRT组肿瘤血管通透性从T2开始增加,T7达最大值,持续至T14
- BB组仅在T7增强血管通透性
- T7时BB较未治疗组增加19.1%(P=.0467),MRT较未治疗组增加44.8%(P<.0001)
- T14时MRT较BB增加22.6%(P=.0199)
关键数值与推荐
- MRT峰剂量241 Gy,谷剂量10.5 Gy
- BB剂量等效于MRT谷剂量10.5 Gy
- T7时BB vs 未治疗:+19.1%,P=.0467
- T7时MRT vs 未治疗:+44.8%,P<.0001
- T14时MRT vs BB:+22.6%,P=.0199
临床怎么用
- MRT可能通过增加肿瘤血管通透性改善药物递送,尤其在高增殖肿瘤区域
- MRT对正常脑组织血管通透性无影响,提示其正常组织保护潜力
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To compare the blood-brain barrier permeability changes induced by synchrotron microbeam radiation therapy (MRT, which relies on spatial fractionation of the incident x-ray beam into parallel micron-wide beams) with changes induced by a spatially uniform synchrotron x-ray radiation therapy. METHODS AND MATERIALS: Male rats bearing malignant intracranial F98 gliomas were randomized into 3 groups: untreated, exposed to MRT (peak and valley dose: 241 and 10.5 Gy, respectively), or exposed to broad beam irradiation (BB) delivered at comparable doses (ie, equivalent to MRT valley dose); both applied by 2 arrays, intersecting orthogonally the tumor region. Vessel permeability was monitored in vivo by magnetic resonance imaging 1 day before (T-1) and 1, 2, 7, and 14 days after treatment start. To determine whether physiologic parameters influence vascular permeability, we evaluated vessel integrity in the tumor area with different values for cerebral blood flow, blood volume, edema, and tissue oxygenation. RESULTS: Microbeam radiation therapy does not modify the vascular permeability of normal brain tissue. Microbeam radiation therapy-induced increase of tumor vascular permeability was detectable from T2 with a maximum at T7 after exposure, whereas BB enhanced vessel permeability only at T7. At this stage MRT was more efficient at increasing tumor vessel permeability (BB vs untreated: +19.1%; P=.0467; MRT vs untreated: +44.8%; P<.0001), and its effects lasted until T14 (MRT vs BB, +22.6%; P=.0199). We also showed that MRT was more efficient at targeting highly oxygenated (high blood volume and flow) and more proliferative parts of the tumor than BB. CONCLUSIONS: Microbeam radiation therapy-induced increased tumor vascular permeability is: (1) significantly greater; (2) earlier and more prolonged than that induced by BB irradiation, especially in highly proliferative tumor areas; and (3) targets all tumor areas discriminated by physiologic characteristics, including those not damaged by homogeneous irradiation.
引用
- Bouchet A, Potez M, Coquery N, et al. Permeability of Brain Tumor Vessels Induced by Uniform or Spatially Microfractionated Synchrotron Radiation Therapies. Int J Radiat Oncol Biol Phys. 2017. PMID: 28721902. doi:10.1016/j.ijrobp.2017.03.025
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。